A.B. Gottlieb

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet · 2001 · 903 citations

Inflammation, Plaque-type Psoriasis, Infliximab Monotherapy +10

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

C. Paul, Jennifer Clay Cather, Melinda Gooderham et al. · British Journal of Dermatology · 2015 · 464 citations · Full text

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study

A.B. Gottlieb, Mark Lebwohl, Amelia Sherr et al. · Journal of the American Academy of Dermatology · 2000 · 129 citations

Autoimmune Disease, Medicine, Immunology +7

Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of <scp>UNCOVER</scp>‐3

P.C.M. van de Kerkhof, Lyn Guenther, A.B. Gottlieb et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 82 citations

Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.

C. Leonardi, Bruce Strober, A.B. Gottlieb et al. · PubMed · 2010 · 76 citations